Tuesday, December 18, 2018
CVS Health initiated at Barclays
CVS Health initiated with an Overweight at Barclays. Barclays analyst Steve Valiquette started CVS Health with an Overweight rating and $91 price target. The analyst views the acquisition of Aetna as well-timed and believes it will offset the company’s slower growth in retail and pharmacy benefits.
https://thefly.com/landingPageNews.php?id=2838477
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.